Postcoronary thrombolysis management.
Massel
D
D
Cairns
J A
JA
Armstrong
P W
PW
Knudtson
M
M
Lemieux
M
M
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D017202:Myocardial Ischemia / Q000517:prevention & control; D011379:Prognosis; D012008:Recurrence; D015912:Thrombolytic Therapy
D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D001241:Aspirin